Binge Eating Disorder Drug Market by Type and Application - Global Industry Analysis & Forecast to 2027

Published On : September 2019 Pages : 170 Category: Pharma & Healthcare Report Code : HC095621

SEGMENTS & REGIONS:

Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Report Description
Table of Content

Binge Eating Disorder Drug Market by Type (Antidepressants, Anti-obesity Medications, Anticonvulsants) Application (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The binge eating disorder drug market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Binge eating disorder is a mental illness whose qualities incorporate repeating scenes of gorging without the influenced person's push to compensate for the gorge scenes by too much working out, cleansing, or potentially improperly utilizing drugs like eating routine pills or intestinal medicines.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global binge eating disorder drug market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
South America
- Brazil
- Argentina
- Columbia
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Roche
Opiant Pharmaceuticals
Chronos Therapeutics
Sunovion Pharmaceuticals
Heptares
Omeros Corp
Novo Nordisk

Some of the key questions answered by the report are:

What was the market size in 2017 and forecast from 2017 to 2027?
What will be the industry market growth from 2017 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

· Binge Eating Disorder Drug Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o Antidepressants

o Anti-obesity Medications

o Anticonvulsants

· Binge Eating Disorder Drug Market, By Applications, Estimates and Forecast, 2017-2027 ($Million)

o Retail Pharmacies

o Hospital Pharmacies

o Online Pharmacies

· Binge Eating Disorder Drug Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o Roche

o Opiant Pharmaceuticals

o Chronos Therapeutics

o Sunovion Pharmaceuticals

o Heptares

o Omeros Corp

o Novo Nordisk

· Binge Eating Disorder Drug Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o North America

§ North America Binge Eating Disorder Drug Market, By Country

o U.S. Binge Eating Disorder Drug Market

o Canada Binge Eating Disorder Drug Market

o Mexico Binge Eating Disorder Drug Market

o Europe

§ Europe Binge Eating Disorder Drug Market, By Country

o Germany Binge Eating Disorder Drug Market

o UK Binge Eating Disorder Drug Market

o France Binge Eating Disorder Drug Market

o Russia Binge Eating Disorder Drug Market

o Italy Binge Eating Disorder Drug Market

o Rest of Europe Binge Eating Disorder Drug Market

o Asia-Pacific

§ Asia-Pacific Binge Eating Disorder Drug Market, By Country

o China Binge Eating Disorder Drug Market

o Japan Binge Eating Disorder Drug Market

o South Korea Binge Eating Disorder Drug Market

o India Binge Eating Disorder Drug Market

o Southeast Asia Binge Eating Disorder Drug Market

o Rest of Asia-Pacific Binge Eating Disorder Drug Market

o South America

§ South America Binge Eating Disorder Drug Market

o Brazil Binge Eating Disorder Drug Market

o Argentina Binge Eating Disorder Drug Market

o Columbia Binge Eating Disorder Drug Market

o Rest of South America Binge Eating Disorder Drug Market

o Middle East and Africa

§ Middle East and Africa Binge Eating Disorder Drug Market

o Saudi Arabia Binge Eating Disorder Drug Market

o UAE Binge Eating Disorder Drug Market

o Egypt Binge Eating Disorder Drug Market

o Nigeria Binge Eating Disorder Drug Market

o South Africa Binge Eating Disorder Drug Market

o Rest of MEA Binge Eating Disorder Drug Market

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2017-2027)

4.1.2. Canada Market Status and Outlook (2017-2027)

4.1.3. Mexico Market Status and Outlook (2017-2027)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2017-2027)

4.2.2. France Market Status and Outlook (2017-2027)

4.2.3. UK Market Status and Outlook (2017-2027)

4.2.4. Russia Market Status and Outlook (2017-2027)

4.2.5. Italy Market Status and Outlook (2017-2027)

4.2.6. Rest of Europe Market Status and Outlook (2017-2027)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2017-2027)

4.3.2. Japan Market Status and Outlook (2017-2027)

4.3.3. Korea Market Status and Outlook (2017-2027)

4.3.4. India Market Status and Outlook (2017-2027)

4.3.5. Southeast Asia Market Status and Outlook (2017-2027)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2017-2027)

4.4.2. Argentina Market Status and Outlook (2017-2027)

4.4.3. Columbia Market Status and Outlook (2017-2027)

4.4.4. Rest of South America Market Status and Outlook (2017-2027)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3. Egypt Market Status and Outlook (2017-2027)

4.5.4. Nigeria Market Status and Outlook (2017-2027)

4.5.5. South Africa Market Status and Outlook (2017-2027)

4.5.6. Turkey Market Status and Outlook (2017-2027)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5. Binge Eating Disorder Drug Market, By Type

5.1. Introduction

5.2. Global Binge Eating Disorder Drug Revenue and Market Share by Type (2017-2027)

5.2.1. Global Binge Eating Disorder Drug Revenue and Revenue Share by Type (2017-2027)

5.3. Antidepressants

5.3.1. Global Antidepressants Revenue and Growth Rate (2017-2027)

5.4. Anti-obesity Medications

5.4.1. Global Anti-obesity Medications Revenue and Growth Rate (2017-2027)

5.5. Anticonvulsants

5.5.1. Global Anticonvulsants Revenue and Growth Rate (2017-2027)

6. Binge Eating Disorder Drug Market, By Application

6.1. Introduction

6.2. Global Binge Eating Disorder Drug Revenue and Market Share by Application (2017-2027)

6.2.1. Global Binge Eating Disorder Drug Revenue and Revenue Share by Application (2017-2027)

6.3. Retail Pharmacies

6.3.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2027)

6.4. Hospital Pharmacies

6.4.1. Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)

6.5. Online Pharmacies

6.5.1. Global Online Pharmacies Revenue and Growth Rate (2017-2027)

7. Binge Eating Disorder Drug Market, By Region

7.1. Introduction

7.2. Global Binge Eating Disorder Drug Revenue and Market Share by Regions

7.2.1. Global Binge Eating Disorder Drug Revenue by Regions (2017-2027)

7.3. North America Binge Eating Disorder Drug by Countries

7.3.1. North America Binge Eating Disorder Drug Revenue and Growth Rate (2017-2027)

7.3.2. North America Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2027)

7.3.3. United States

7.3.3.1. United States Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4. Canada

7.3.4.1. Canada Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5. Mexico

7.3.5.1. Mexico Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4. Europe Binge Eating Disorder Drug by Countries

7.4.1. Europe Binge Eating Disorder Drug Revenue and Growth Rate (2017-2027)

7.4.2. Europe Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2027)

7.4.3. Germany

7.4.3.1. Germany Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4. France

7.4.4.1. France Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5. UK

7.4.5.1. UK Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6. Russia

7.4.6.1. Russia Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7. Italy

7.4.7.1. Italy Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8. Rest of Europe

7.4.8.1. Rest of Europe Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5. Asia-Pacific Binge Eating Disorder Drug by Countries

7.5.1. Asia-Pacific Binge Eating Disorder Drug Revenue and Growth Rate (2017-2027)

7.5.2. Asia-Pacific Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2027)

7.5.3. China

7.5.3.1. China Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4. Japan

7.5.4.1. Japan Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5. Korea

7.5.5.1. Korea Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6. India

7.5.6.1. India Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7. Southeast Asia

7.5.7.1. Southeast Asia Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8. Rest of Asia-Pacific

7.5.8.1. Rest of Asia-Pacific Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.6. South America Binge Eating Disorder Drug by Countries

7.6.1. South America Binge Eating Disorder Drug Revenue and Growth Rate (2017-2027)

7.6.2. South America Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2027)

7.6.3. Brazil

7.6.3.1. Brazil Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4. Argentina

7.6.4.1. Argentina Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5. Columbia

7.6.5.1. Columbia Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6. Rest of South America

7.6.6.1. Rest of South America Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7. Middle East and Africa Binge Eating Disorder Drug by Countries

7.7.1. Middle East and Africa Binge Eating Disorder Drug Revenue and Growth Rate (2017-2027)

7.7.2. Middle East and Africa Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2027)

7.7.3. Saudi Arabia

7.7.3.1. Saudi Arabia Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4. United Arab Emirates

7.7.4.1. United Arab Emirates Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5. Egypt

7.7.5.1. Egypt Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6. Nigeria

7.7.6.1. Nigeria Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7. South Africa

7.7.7.1. South Africa Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8. Turkey

7.7.8.1. Turkey Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9. Rest of Middle East and Africa

7.7.9.1. Rest of Middle East and Africa Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

8. Company Profiles

8.1. Roche

8.1.1. Business Overview

8.1.2. Service Portfolio

8.1.3. Strategic Developments

8.1.4. Financial Overview

8.2. Opiant Pharmaceuticals

8.2.1. Business Overview

8.2.2. Service Portfolio

8.2.3. Strategic Developments

8.2.4. Financial Overview

8.3. Chronos Therapeutics

8.3.1. Business Overview

8.3.2. Service Portfolio

8.3.3. Strategic Developments

8.3.4. Financial Overview

8.4. Sunovion Pharmaceuticals

8.4.1. Business Overview

8.4.2. Service Portfolio

8.4.3. Strategic Developments

8.4.4. Financial Overview

8.5. Heptares

8.5.1. Business Overview

8.5.2. Service Portfolio

8.5.3. Strategic Developments

8.5.4. Financial Overview

8.6. Omeros Corp

8.6.1. Business Overview

8.6.2. Service Portfolio

8.6.3. Strategic Developments

8.6.4. Financial Overview

8.7. Novo Nordisk

8.7.1. Business Overview

8.7.2. Service Portfolio

8.7.3. Strategic Developments

8.7.4. Financial Overview

9. Binge Eating Disorder Drug Market Forecast (2017-2027)

9.1. Global Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2027)

9.2. Binge Eating Disorder Drug Market Forecast by Regions (2017-2027)

9.2.1. North America Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.1.1. United States Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.1.2. Canada Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.1.3. Mexico Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.2. Europe Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.2.1. Germany Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.2.2. France Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.2.3. UK Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.2.4. Russia Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.2.5. Italy Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.2.6. Rest of Europe Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.3. Asia-Pacific Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.3.1. China Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.3.2. Japan Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.3.3. Korea Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.3.4. India Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.3.5. Southeast Asia Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.3.6. Rest of Asia-Pacific Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.4. South America Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.4.1. Brazil Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.4.2. Argentina Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.4.3. Columbia Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.4.4. Rest of South America Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.5. Middle East and Africa Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.5.1. Saudi Arabia Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.5.2. United Arab Emirates Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.5.3. Egypt Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.5.4. Nigeria Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.5.5. South Africa Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.5.6. Turkey Binge Eating Disorder Drug Market Forecast (2017-2027)

9.2.5.7. Rest of Middle East and Africa Binge Eating Disorder Drug Market Forecast (2017-2027)

9.3. Binge Eating Disorder Drug Market Forecast by Type (2017-2027)

9.3.1. Binge Eating Disorder Drug Forecast by Type (2017-2027)

9.3.2. Binge Eating Disorder Drug Market Share Forecast by Type (2017-2027)

9.4. Binge Eating Disorder Drug Market Forecast by Application (2017-2027)

9.4.1. Binge Eating Disorder Drug Forecast by Application (2017-2027)

9.4.2. Binge Eating Disorder Drug Market Share Forecast by Application (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Binge Eating Disorder Drug Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Binge Eating Disorder Drug Revenue and Revenue Share by Type (2017-2018)
Figure Global Antidepressants Revenue and Growth Rate (2017-2018)
Figure Global Anti-obesity Medications Revenue and Growth Rate (2017-2018)
Figure Global Anticonvulsants Revenue and Growth Rate (2017-2018)
Table Global Binge Eating Disorder Drug Revenue and Revenue Share by Application (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Online Pharmacies Revenue and Growth Rate (2017-2018)
Table Global Binge Eating Disorder Drug Revenue by Regions (2017-2018)
Figure North America Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure North America Binge Eating Disorder Drug Revenue and Growth Rate (2017-2018)
Figure North America Binge Eating Disorder Drug by Countries (2017-2018)
Figure North America Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2018)
Figure United States Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure United States Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Canada Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Mexico Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Europe Binge Eating Disorder Drug Revenue and Growth Rate (2017-2018)
Figure Europe Binge Eating Disorder Drug by Countries (2017-2018)
Figure Europe Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2018)
Figure Germany Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Germany Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure France Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure UK Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Russia Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Italy Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Rest of Europe Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Asia-Pacific Binge Eating Disorder Drug Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Binge Eating Disorder Drug by Countries (2017-2018)
Figure Asia-Pacific Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2018)
Figure China Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure China Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Japan Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Korea Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure India Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Southeast Asia Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure South America Binge Eating Disorder Drug Revenue and Growth Rate (2017-2018)
Figure South America Binge Eating Disorder Drug by Countries (2017-2018)
Figure South America Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Brazil Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Argentina Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Columbia Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Rest of South America Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Middle East and Africa Binge Eating Disorder Drug Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Binge Eating Disorder Drug by Countries (2017-2018)
Figure Middle East and Africa Binge Eating Disorder Drug Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Saudi Arabia Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure United Arab Emirates Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Egypt Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Nigeria Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure South Africa Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Turkey Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Binge Eating Disorder Drug Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2017-2018)
Table Roche Binge Eating Disorder Drug Financial Overview
Table Opiant Pharmaceuticals Binge Eating Disorder Drug Financial Overview
Table Chronos Therapeutics Binge Eating Disorder Drug Financial Overview
Table Sunovion Pharmaceuticals Binge Eating Disorder Drug Financial Overview
Table Heptares Binge Eating Disorder Drug Financial Overview
Table Omeros Corp Binge Eating Disorder Drug Financial Overview
Table Novo Nordisk Binge Eating Disorder Drug Financial Overview
Figure Global Binge Eating Disorder Drug Revenue (Millions USD) and Growth Rate (2018-2025)
Table Binge Eating Disorder Drug Market Forecast by Regions (2018-2025)
Figure North America Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure United States Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Canada Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Mexico Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Europe Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Germany Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure France Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure UK Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Russia Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Italy Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Rest of Europe Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Asia-Pacific Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure China Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Japan Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Korea Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure India Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Southeast Asia Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure South America Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Brazil Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Argentina Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Columbia Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Rest of South America Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Middle East and Africa Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Saudi Arabia Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure United Arab Emirates Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Egypt Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Nigeria Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure South Africa Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Turkey Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Binge Eating Disorder Drug Market Forecast (2018-2025)
Figure Global Binge Eating Disorder Drug Forecast by Type (2018-2025)
Figure Global Binge Eating Disorder Drug Market Share Forecast by Type (2018-2025)
Figure Global Binge Eating Disorder Drug Forecast by Type (2018-2025)
Figure Global Binge Eating Disorder Drug Forecast by Application (2018-2025)
Figure Global Binge Eating Disorder Drug Market Share Forecast by Application (2018-2025)
Figure Global Binge Eating Disorder Drug Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

Number of patients for particular device or medical procedure and
Repeated use of particular device depending on health and condition of patient

Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample

Requirement/Comment